Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model

In this study, the efficacy of orally and parenter-ally administered curcumin was evaluated in non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice (NOD.CB17-Prkdc(scid)/J mice) engrafted with the human t(4;11) acute lymphoblastic leukemia line, SEM. SEM cells were injected into the ta...

Descripción completa

Detalles Bibliográficos
Autores principales: ZUNINO, SUSAN J., STORMS, DAVID H., NEWMAN, JOHN W., PEDERSEN, THERESA L., KEEN, CARL L., DUCORE, JONATHAN M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583839/
https://www.ncbi.nlm.nih.gov/pubmed/23232667
http://dx.doi.org/10.3892/ijo.2012.1734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583839/
https://www.ncbi.nlm.nih.gov/pubmed/23232667
http://dx.doi.org/10.3892/ijo.2012.1734

Ejemplares similares